SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,658.24 149.83
(0.29%)

Dow Jones

7,594.79 30.15
(0.40%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,498.02 25.57
(0.24%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

193.062981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

51.34

13643

EPS(TTM)

Face Value()

Div & Yield %

25.4

0.58

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	1055.07	1200.09	1016.94	853.17	712.93	616.94
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1055.07	1200.09	1016.94	853.17	712.93	616.94
Other Income	52.73	44.45	33.78	35.31	23.42	13.81
Stock Adjustments	70.61	14.79	12.08	15.63	23.98	39.05
Total Income	1178.41	1259.33	1062.80	904.11	760.33	669.80
EXPENDITURE :
Raw Materials	316.58	320.30	241.28	195.84	187.99	150.61
Power & Fuel Cost	116.20	112.23	104.97	97.65	71.64	39.86
Employee Cost	170.19	138.93	123.05	110.28	95.69	69.47
Other Manufacturing Expenses	30.77	26.18	28.00	24.93	17.10	12.99
Selling & Administrative Expenses	100.88	99.31	91.08	82.93	67.90	44.87
Miscellaneous Expenses	17.28	11.09	8.46	13.20	22.66	10.26
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	751.89	708.03	596.83	524.84	462.99	328.05
Operating Profit	426.53	551.29	465.97	379.27	297.34	341.74
Interest	0.77	1.04	3.18	5.18	6.13	1.05
Gross Profit	425.76	550.25	462.79	374.09	291.21	340.69
Depreciation	74.33	54.37	53.59	54.03	50.05	27.52
Profit Before Tax	351.43	495.88	409.20	320.06	241.16	313.17
Tax	86.29	118.96	99.83	79.53	58.49	75.72
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.87	3.95	4.63	2.40	4.10	2.11
Reported Net Profit	263.27	372.96	304.73	238.13	178.57	235.33
Extraordinary Items	22.35	27.50	10.48	2.70	3.86	5.24
Adjusted Net Profit	240.92	345.46	294.25	235.43	174.71	230.09
Adjustment below Net Profit	55.78	5.97	-0.01	0.26	-0.56	-0.04
P & L Balance brought forward	1691.00	1403.60	1170.33	985.51	878.02	648.43
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	111.94	91.54	71.45	53.56	70.52	5.71
P & L Balance carried down	1898.10	1691.00	1403.60	1170.33	985.51	878.02
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	755.00	875.00	875.00	683.00	51.20	0.00
Dividend Per Share(Rs)	7.55	10.70	8.75	6.83	5.12	0.00
Earnings Per Share-Unit Curr	25.17	35.65	29.13	22.76	187.76	247.44
Earnings Per Share(Adj)-Unit Curr	25.17	35.65	29.13	22.76	187.76	247.44
Book Value-Unit Curr	193.06	173.27	145.80	123.50	1164.13	1051.11
Book Value(Adj)-Unit Curr	193.06	173.27	145.80	123.50	1164.13	1051.11

77,569.39 827.57 ( 1.08%)

52,658.24 149.83 (0.29%)

7,594.79 30.15 (0.40%)

68,634.11 890.26 (1.31%)

10,498.02 25.57 (0.24%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)